Physician profile
Arpan Patel
NPI 1154509735
$6,106.67
in general payments reported to CMS, 2019-2025
30 companies · $1,087 in 2025
The $1,087 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,794 · 2020: $105 · 2021: $94.41 · 2022: $217 · 2023: $2,088 · 2024: $721 · 2025: $1,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,673 · Food and Beverage: $1,207 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,673.31 |
| Food and Beverage | $1,207.34 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $928.21 | 2023 | Sacroiliac Joint Fusion System |
| Spr Therapeutics, INC | $797.70 | 2023 | Sprint Pns System |
| Si-Bone, INC. | $750.63 | 2019-2025 | |
| Curonix LLC | $720.70 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $602.93 | 2019-2025 | Proclaim |
| Medtronic USA, INC. | $446.63 | 2019 | |
| Boston Scientific Corporation | $290.75 | 2019-2025 | Intracept |
| Foundation Fusion Solutions, LLC | $278.52 | 2025 | |
| Novartis Pharmaceuticals Corporation | $227.34 | 2019-2020 | |
| Nevro Corp. | $147.00 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $134.45 | 2019 | |
| Pfizer INC. | $98.52 | 2019-2020 | |
| Medtronic, INC. | $87.18 | 2022-2023 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $73.88 | 2019 | |
| Assertio Therapeutics, INC. | $69.34 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60.69 | 2019 | |
| Allergan, INC. | $60.40 | 2019 | |
| Lilly USA, LLC | $50.24 | 2019 | |
| Ibsa Pharma INC. | $39.73 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $33.37 | 2019 | |
| Biodelivery Sciences International, INC. | $29.38 | 2019 | |
| Shionogi INC | $25.04 | 2019 | |
| Pacira Therapeutics, INC. | $24.67 | 2019 | |
| Orthogenrx INC. | $24.40 | 2019 | |
| Vertiflex, INC. | $20.54 | 2019 | |
| Mdd US Operations, LLC | $19.04 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.37 | 2021 | |
| Almatica Pharma LLC | $17.89 | 2022 | |
| Spinal Simplicity, LLC | $16.81 | 2025 | Ha Minuteman G3-R |
| Fidia Pharma USA INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.